Skip to main content

Table 3 Triads with a prevalence ≥ 1% and an observed/expected ratio ≥ 2 by multimorbidity clusters in the male population with ≥ 3 chronic conditions (n = 54.987)

From: Reducing complexity: a visualisation of multimorbidity by combining disease clusters and triads

Cardiovascular and metabolic disorders

O/E-ratio

Prevalence in %

Obesity + Hyperuricemia/Gout + Liver diseases

3.5

1.3

Chronic ischemic heart disease + Cardiac arrhythmias + Cardiac insufficiency

3.3

1.7

Diabetes mellitus + Atherosclerosis/PAOD + Neuropathies

3.3

1.4

Chronic ischemic heart disease + Cardiac arrhythmias + Cardiac valve disorders

3.2

1.2

Diabetes mellitus + Obesity + Liver diseases

3.0

1.5

Severe vision reduction + Diabetes mellitus + Neuropathies

3.0

1.5

Chronic ischemic heart disease + Atherosclerosis/PAOD + Renal insufficiency

2.9

1.2

Chronic ischemic heart disease + Atherosclerosis/PAOD + Cardiac insufficiency

2.9

1.2

Diabetes mellitus + Atherosclerosis/PAOD + Renal insufficiency

2.6

1.1

Chronic ischemic heart disease + Hyperuricemia/Gout + Renal insufficiency

2.5

1.5

Chronic ischemic heart disease + Cardiac arrhythmias + Renal insufficiency

2.4

1.3

Chronic ischemic heart disease + Atherosclerosis/PAOD + Cerebral ischemia/Chronic stroke

2.4

1.3

Diabetes mellitus + Atherosclerosis/PAOD + Cerebral ischemia/Chronic stroke

2.4

1.2

Hypertension + Renal insufficiency + Cardiac insufficiency

2.4

1.1

Lipid metabolism disorders + Hyperuricemia/Gout + Liver diseases

2.3

3.5

Diabetes mellitus + Hyperuricemia/Gout + Liver diseases

2.3

2.3

Diabetes mellitus + Obesity + Hyperuricemia/Gout

2.3

1.9

Lipid metabolism disorders + Obesity + Liver diseases

2.3

1.7

Diabetes mellitus + Hyperuricemia/Gout + Renal insufficiency

2.3

1.4

Diabetes mellitus + Cardiac arrhythmias + Cardiac insufficiency

2.3

1.2

Hypertension + Urinary incontinence + Cancers

2.3

1.1

Lipid metabolism disorders + Hyperuricemia/Gout + Renal insufficiency

2.2

2.1

Diabetes mellitus + Chronic ischemic heart disease + Cardiac insufficiency

2.2

1.8

Hypertension + Cardiac arrhythmias + Cardiac valve disorders

2.1

1.8

Diabetes mellitus + Chronic ischemic heart disease + Renal insufficiency

2.1

1.7

Lipid metabolism disorders + Cardiac arrhythmias + Cardiac valve disorders

2.1

1.2

Chronic ischemic heart disease + Hyperuricemia/Gout + Cardiac insufficiency

2.1

1.2

Hyperuricemia/Gout + Liver diseases + Atherosclerosis/PAOD

2.1

1.1

Hypertension + Hyperuricemia/Gout + Renal insufficiency

2.0

2.7

Lipid metabolism disorders + Obesity + Hyperuricemia/Gout

2.0

2.7

Hypertension + Obesity + Liver diseases

2.0

2.3

Hypertension + Cardiac arrhythmias + Cardiac insufficiency

2.0

2.3

Diabetes mellitus + Chronic ischemic heart disease + Neuropathies

2.0

1.7

Lipid metabolism disorders + Atherosclerosis/PAOD + Cerebral ischemia/Chronic stroke

2.0

1.6

Chronic low back pain + Cardiac arrhythmias + Cardiac valve disorders

2.0

1.0

Anxiety, depression, somatoform disorders and pain

O/E

%

Chronic low back pain + Hemorrhoids + Chronic gastritis/GERD

2.5

1.0

Chronic low back pain + Joint arthrosis + Hemorrhoids

2.3

1.6

Chronic low back pain + Prostatic hyperplasia + Sexual dysfunction

2.3

1.2

Chronic low back pain + Joint arthrosis + Lower limb varicosis

2.2

2.5

Chronic low back pain + Joint arthrosis + Intestinal diverticulosis

2.2

1.4

Chronic low back pain + Depression + Chronic gastritis/GERD

2.2

1.1

Chronic low back pain + Prostatic hyperplasia + Hemorrhoids

2.1

1.6

Chronic low back pain + Joint arthrosis + Insomnia

2.1

1.3

Chronic low back pain + Joint arthrosis + Severe hearing loss

2.1

1.1

Both multimorbidity patterns

O/E

%

Chronic ischemic heart disease + Asthma/COPD + Cardiac insufficiency

2.5

1.0

Chronic low back pain + Joint arthrosis + Neuropathies

2.2

1.8

Chronic low back pain + Obesity + Liver diseases

2.2

1.4

Chronic low back pain + Atherosclerosis/PAOD + Neuropathies

2.1

1.1

Joint arthrosis + Obesity + Hyperuricemia/Gout

2.0

1.4

Hyperuricemia/Gout + Liver diseases + Asthma/COPD

2.0

1.1

Hyperuricemia/Gout + Prostatic hyperplasia + Renal insufficiency

2.0

1.1

  1. O/E: observed/expected ratio; PAOD: peripheral arterial occlusive disease; COPD: chronic obstructive pulmonary disease; GERD: gastroesophageal reflux disease.
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us